Terug
Dagbereik
€ 24,96
€ 26,38
52-Weeksbereik
€ 9,98
€ 29,65
Volume
2.089.481
50D / 200D Gem.
€ 21,55
/
€ 17,77
Vorige Slotkoers
€ 24,82
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -8,4 | 0,4 |
| P/B | 11,1 | 2,9 |
| ROE % | -97,9 | 3,7 |
| Net Margin % | -20,2 | 3,8 |
| Rev Growth 5Y % | 9,6 | 10,0 |
| D/E | 2,9 | 0,2 |
Belangrijkste Punten
Revenue grew 9,62% annually over 5 years — modest growth
Debt/Equity of 2,86 — high leverage
Negative free cash flow of -29,67M
Capital efficient — spends only 1,97% of revenue on capex
Groei
Revenue Growth (5Y)
9,62%
Revenue (1Y)7,93%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-97,88%
ROIC-9,77%
Net Margin-20,17%
Op. Margin-7,70%
Veiligheid
Debt / Equity
2,86
Current Ratio2,55
Interest Coverage-9,88
Waardering
P/E Ratio
-8,37
P/B Ratio11,05
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,93% | Revenue Growth (3Y) | 16,50% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9,62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,01B | Net Income (TTM) | -204,71M |
| ROE | -97,88% | ROA | -23,23% |
| Gross Margin | 52,31% | Operating Margin | -7,70% |
| Net Margin | -20,17% | Free Cash Flow (TTM) | -29,67M |
| ROIC | -9,77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,86 | Current Ratio | 2,55 |
| Interest Coverage | -9,88 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -8,37 | P/B Ratio | 11,05 |
| P/S Ratio | 1,69 | PEG Ratio | -0,07 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,71B | Enterprise Value | 2,07B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,01B | 940,20M | 747,72M | 801,22M | 702,80M |
| Net Income | -204,71M | -96,03M | -222,61M | -94,59M | 15,57M |
| EPS (Diluted) | -3,04 | -1,47 | -3,43 | -1,47 | 0,24 |
| Gross Profit | 530,85M | 489,57M | 367,69M | 412,99M | 376,22M |
| Operating Income | -78,12M | -99,13M | -233,23M | -92,85M | 22,65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 881,11M | 967,66M | 952,66M | 1,05B | 905,14M |
| Total Liabilities | 725,94M | 704,56M | 639,03M | 612,84M | 472,03M |
| Shareholders' Equity | 155,17M | 263,10M | 313,63M | 439,95M | 433,11M |
| Total Debt | 444,48M | 473,57M | 415,67M | 419,88M | 314,67M |
| Cash & Equivalents | 90,63M | 69,23M | 58,87M | 172,52M | 71,18M |
| Current Assets | 618,14M | 724,49M | 747,99M | 849,98M | 811,52M |
| Current Liabilities | 242,72M | 247,05M | 195,26M | 165,29M | 131,86M |